ETF Building Blocks Channel Innovation Could Propel Biotechnology Bounce By Todd ShriberOctober 31, 2023
Featured Putnam Launches 2 Active ETFs Targeting BDCs and Biotechnology By James ComtoisSeptember 30, 2022
Beyond Basic Beta Channel Using Biotechnology Stocks to Help Navigate the Ongoing COVID Crisis By VanEckDecember 11, 2021
Innovative ETFs Channel Moderna’s Omicron Booster Strategy Lifts Biotechnology ETFs By Max ChenNovember 29, 2021
Nasdaq Investment Intelligence Channel New Biotechnology ETF Could Be a Stellar Second Half Idea By Tom LydonJuly 1, 2021
Innovative ETFs Channel Biotechnology ETFs Soar on Biogen’s New Alzheimer’s Drug By Max ChenJanuary 29, 2021
Nasdaq Investment Intelligence Channel Small-Cap Biotechnology ETF Brings Big Opportunity By Tom LydonSeptember 9, 2020
ETF of the Week ETF of the Week: Defiance Nasdaq Junior Biotechnology ETF (IBBJ) By Aaron NeuwirthAugust 20, 2020
Nasdaq Investment Intelligence Channel Defiance Debuts Nasdaq Junior Biotechnology ETF (IBBJ) By Brenton GarenAugust 4, 2020
Innovative ETFs Channel Get Next-Level Biotechnology Exposure with the “GDNA” ETF By Ben HernandezJuly 6, 2020
Disruptive Technology Channel This Biotechnology ETF Could Be the Place to Be in a Recession By Tom LydonApril 27, 2020
Disruptive Technology Channel 2 Biotechnology ETFs That Could Be Good For Diversification By Ian YoungMarch 26, 2020
